Torrent Pharmaceuticals Limited (NSE: TORNTPHARM)
India
· Delayed Price · Currency is INR
3,101.95
+7.10 (0.23%)
Nov 21, 2024, 3:30 PM IST
Torrent Pharmaceuticals Revenue
Torrent Pharmaceuticals had revenue of 28.89B INR in the quarter ending September 30, 2024, with 8.61% growth. This brings the company's revenue in the last twelve months to 112.24B, up 9.68% year-over-year. In the fiscal year ending March 31, 2024, Torrent Pharmaceuticals had annual revenue of 107.28B with 11.51% growth.
Revenue (ttm)
112.24B
Revenue Growth
+9.68%
P/S Ratio
n/a
Revenue / Employee
7.14M
Employees
15,718
Market Cap
1,050.72B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 107.28B | 11.08B | 11.51% |
Mar 31, 2023 | 96.20B | 11.12B | 13.07% |
Mar 31, 2022 | 85.08B | 5.03B | 6.29% |
Mar 31, 2021 | 80.05B | 652.60M | 0.82% |
Mar 31, 2020 | 79.39B | 2.67B | 3.47% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTorrent Pharmaceuticals News
- 22 days ago - Torrent Pharma Block Deal: 1.04 crore shares or 3% equity worth Rs 3,230 crore change hands - Business Upturn
- 22 days ago - Stock to watch today: Torrent Pharma promoter to sell up to 2.9% stake via block deal: Report - Business Upturn
- 24 days ago - Torrent Pharmaceuticals shares in focus as Q2 profit rises 17.4% to ₹453 crore - Business Upturn
- 2 months ago - Torrent counters faulty drug claim - The Times of India
- 2 months ago - Torrent Pharma announces US FDA’s inspection conclusion at Madhya Pradesh facility, shares surge over 2% - Business Upturn
- 2 months ago - Torrent Pharma shares surge around 2% after USFDA inspection closure - Business Upturn
- 2 months ago - Torrent Pharma’s Indrad facility receives USFDA EIR with VAI Classification - Business Upturn